Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Wereldwijd onderzoek naar genetica teruggekeerde hersentumoren
dec 2019 | Neuro-oncologie